Creo Medical Group PLC (AIM:CREO)

Market Cap	47.63M +6.4%
Revenue (ttm)	7.00M +62.8%
Net Income	-20.10M
EPS	-0.05
Shares Out	448.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	215,309
Open	10.32
Previous Close	10.38
Day's Range	10.25 - 11.00
52-Week Range	9.50 - 18.50
Beta	0.96
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 23, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 104
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error